The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Forty Seven; Gilead Sciences
Leadership - Forty Seven; Gilead Sciences; Hepatx; IconOVir Bio; TigaTx
Stock and Other Ownership Interests - Celldex; Forty Seven; Gilead Sciences; Nektar; Trillium Therapeutics
Consulting or Advisory Role - Forest Laboratories; Hepatx; IconOVir Bio; TigaTx
Patents, Royalties, Other Intellectual Property - Forty Seven; Gilead Sciences; Hepatx
Other Relationship - Leukemia and Lymphoma Society
Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk (HR) myelodysplastic syndrome (MDS): The phase 3, randomized, ENHANCE study.
 
Guillermo Garcia-Manero
Honoraria - Abbvie; Acceleron Pharma; Astex Pharmaceuticals; Celgene; Helsinn Healthcare
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Bristol-Myers Squibb; Celgene; Helsinn Therapeutics; Jazz Pharmaceuticals
Research Funding - Abbvie; Amphivena; Astex Pharmaceuticals; Bristol-Myers Squibb; celgene; H3 Biomedicine; Helsinn Therapeutics; Merck; Novartis; Onconova Therapeutics
 
Naval Guastad Daver
Honoraria - Abbvie; Astellas Pharma; BMS; Immunogen; Incyte; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech; Immunogen; Incyte; Jazz Pharmaceuticals; Karyopharm Therapeutics; Novartis; Otsuka; Pfizer; SERVIER; Sunesis Pharmaceuticals; Syndax; Trillium Therapeutics
Research Funding - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo; Genentech; Immunogen; Incyte; Karyopharm Therapeutics; Nohla Therapeutics; Novartis; Pfizer; Servier; SOBI; Sunesis Pharmaceuticals
 
Jin Xu
Employment - Gilead Sciences
Stock and Other Ownership Interests - Forty Seven; Gilead Sciences; Roche
 
Mark Chao
No Relationships to Disclose
 
Trisha Chung
Employment - Forty Seven; Gilead Sciences; Loxo
Stock and Other Ownership Interests - Forty Seven; Gilead Sciences; Loxo
 
Anderson Tan
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Vivian Wang
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen Oncology; Macrogenics; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
 
Paresh Vyas
Stock and Other Ownership Interests - OxStem
Honoraria - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Pfizer
Research Funding - Celgene; Forty Seven
Patents, Royalties, Other Intellectual Property - Patent for flow cytometric detection of leukaemic stem cells
 
David Andrew Sallman
Consulting or Advisory Role - Abbvie; Agios; Aprea AB; Bristol-Myers Squibb; Celyad; Gilead Sciences; Intellia Therapeutics; Kite, a Gilead company; Magenta Therapeutics; Novartis; Syndax
Speakers' Bureau - Agios; Bristol-Myers Squibb; Incyte
Research Funding - Celgene; Jazz Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Intellectual Property Patent for LB-100 in MDS